when will compounded tirzepatide no longer be available Update: On December 19th the FDA ruled the tirzepatide shortage was resolved, however is giving a grace period for compounding pharmacies to continuing manufacturing. This grace period is 60 days. On June/July 2026 Changes to Tirzepatide

This approach could allow you to enjoy the appetite-suppressing effects of GLP-1s without the full range of side effects commonly seen with higher doses used in diabetes treatment

On average, tirzepatide weight loss results in just over a year (72 weeks) are: 15% weight loss on 5 mg 19.5% weight loss on 10 mg 20.9% weight loss on 15 mg So, for a 200-pound person, this works out to: 30 pounds on 5 mg 40 pounds on 10 mg 42 pounds on 15 mg In comparison, people who did not take tirzepatide lost only 3.1% of their body weight (about 6 pounds for a 200-pound person)

The importance of regular consultations with medical professionals cannot be overstated, as these interactions facilitate necessary adjustments to treatment and ensure that women can safely benefit from this medication

This principle applies to all peptides, not just tirzepatide

00:04:32 Vickie Danaher So GLP-1 agonist medications activate these same receptors, helping people feel full sooner, staying fuller longer, and ultimately eating less